Here’s some interesting news from the obesity drug front. First off, Aetna, one of the nation’s largest insurers, announced Wednesday that it was going to provide coverage for prescription obesity medications including Qsymia and Belviq. Many insurance companies have been dragging their feet on reimbursing for the drugs -- approved by the US Food and Drug Administration this past summer -- which has led to a lag in sales.

Aetna’s move could pave the way for more insurance companies to follow suit, Reuters reports.